BioLife Solutions (BLFS) Tops Q1 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $38.61 --0%
EPS Growth %: +400.0%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +400.0%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q1 EPS of ($0.17), $0.08 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $36.2 million versus the consensus estimate of $38.2 million.
GUIDANCE:
BioLife Solutions sees FY2022 revenue of $159.5-171 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- AI chip sell-off is ‘unmoored from fundamentals,’ LYNX says
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
